• Most Popular
  • Most Shared

Nastech Pharm announces issuance of a U.S. Patent for Nascobal nasal spray

Tue Jun 12, 2007 9:16am EDT
Co announced the issuance of a U.S. patent, No. 7,229,636, from the U.S. Patent and Trademark Office, titled "Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery." Issuance of this patent triggers an obligation by QOL Medical LLC to pay Nastech a $2 million milestone under the license agreement granting QOL Medical commercialization rights to Nascobal Nasal Spray.



More from Reuters

Photo

Plot exposes fissure in U.S. intelligence community

WASHINGTON (Reuters) - Last week's failed plot to bomb a U.S. passenger jet has exposed lingering fissures within the U.S. intelligence community, which had information from interviews and clandestine intercepts but did not put the pieces together, officials said.

» More Top News
Floor traders work at the Hong Kong Stocks Exchange, January 16, 2008. REUTERS/Bobby Yip

My way or the highway?

Hong Kong is poised to accept Beijing's accounting standards. That's good. The system, though, is prone to scandal. That's bad.  Full Article 

Global Markets
People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid
Rolfe Winkler:

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article 

    Commentary